We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How investigators and sponsors should manage clinical trials during COVID-19
This collection brings together information for local councils on climate change and the environment.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Pharmacovigilance system requirements
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Guidance for those affected by changes to UK immigration and borders due to coronavirus.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Blogs where government organisations talk about their work and share information and ideas.
This amended guidance was issued under s 182 of the Licensing Act 2003.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Find out how to prove the originating status of your goods and check if you can claim preferential tariff treatment.
Updates, news and events from the UK government in USA
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
This series brings together all documents relating to Research news
FCDO travel advice for Honduras. Includes safety and security, insurance, entry requirements and legal differences.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Important Safety Message from OPSS.
Find information and support on woodland creation in England, including funding to create woodland, legal requirements and best practice for sustainability.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.